The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Articles
Search our media releases, news, safety updates (medicines and medical devices), vaccine safety reports, and notices.
Loading...
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Legislation (6)
- Prescription medicines (34)
- Medicine safety (28)
- Therapeutic goods regulation (17)
- Regulatory compliance (14)
- COVID-19 (13)
- Medical devices safety (9)
- Complementary medicines (8)
- Non-prescription medicines (8)
- Safety (8)
- Advertising (7)
- Australian Register of Therapeutic Goods (ARTG) (7)
- Labelling and packaging (7)
- Shortages (7)
- Alert/Advisory (6)
- In Vitro Diagnostic medical devices (IVDs) (6)
- Manufacturing (6)
- Listed medicines (5)
- Over the counter (OTC) medicines (5)
- Scheduling (national classification system) (5)
- Sunscreens (5)
- Vaping hub (5)
- Advisory bodies and committees (4)
- Assessed listed medicines (3)
- Medicinal cannabis hub (3)
- Clinical trials (2)
- Weight loss products (2)
- Advanced therapies (1)
- Blood and blood components (1)
- Blood safety (1)
- Cosmetics (1)
- Fees and payments (1)
- Import and export (1)
- Unique Device Identification (UDI) hub (1)
Search
6 result(s) found, displaying 1 to 6
-
NewsFind out about new requirements for labels of injectable electrolyte medicines and updates to guidance for medicine sponsors.
-
NewsFollowing our Essential Principles presentations on 11-12 September 2024, we have collated questions asked into themes to simplify finding information of relevance to you.
-
NewsTwo new quality standards, one for MDMA and another for psilocybine, have been published.
-
NewsSome changes are rolling out soon to improve your experience using guidance on our website. We’re aiming to make our content clearer, more accessible and easier to navigate.
-
NewsEssential principle 7 now mentions nanomaterials explicitly (see EP 7.7)
-
NewsThe new Therapeutic Goods (Medicines Advisory Statements) Specification 2021 commences 1 January 2022